AstraZeneca PLC header image

AstraZeneca PLC

AZN

Equity

ISIN GB0009895292 / Valor 982352

LSE London Stock Exchange, SETS (2026-03-27)
GBP 143.02+3.41%

AstraZeneca PLC
UMushroom community rating:

star star star star star
4.05 20 votes No rating yet
NegativeNeutralPositive

About company

AstraZeneca PLC is a global pharmaceutical company with a focus on the discovery, development, and commercialization of prescription medicines across various therapy areas. The company is science-led and patient-focused, aiming to address unmet medical needs by bringing innovative medicines to market. AstraZeneca operates in key therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology, with a growing pipeline in rare diseases. Its business strategy emphasizes growth through innovation, leveraging advanced therapeutic modalities and engaging in strategic partnerships to enhance healthcare outcomes. AstraZeneca's commitment to healthcare extends to improving access to its medicines globally, ensuring it plays a significant role in transforming the future of healthcare.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

27.7%1Y
27.1%3Y
97.4%5Y

Performance

26.4%1Y
23.7%3Y
23.6%5Y

Volatility

Market cap

294248 M

Market cap (USD)

Daily traded volume (Shares)

1,463,421

Daily traded volume (Shares)

1 day high/low

104.82 / 103.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.05

20 votes
Performance:
starstarstarstarstar
3.68
Innovation:
starstarstarstarstar
4.28
Society:
starstarstarstarstar
3.75
Nature:
starstarstarstarstar
3.43
Aran Grant
United Kingdom, 09 Nov 2025
star star star star star
Health stocks nice and stable
Deny Purwanto
United Kingdom, 09 Nov 2025
star star star star star
.
Korbinian Kramer
United Kingdom, 08 Nov 2025
star star star star star
Strong growth due to the comapnies strength in innovation and high drug demand

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.82%USD 72.15
Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 131.87
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.98%USD 18.16
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%CHF 312.50
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.17%USD 166.38
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.56%USD 510.68
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%EUR 4.30
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.65%USD 1.67
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 3.56